NCR300

· Nuwacell Biotechnologies Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NCR300, covering 2024-06-04 to 2024-06-04. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation [Phase 1]

See pricing